Gene expression profiling of multiple leiomyomata uteri and matched normal tissue from a single patient

Fertility and Sterility

Volumn 91, Issue 6, 2009, Pages 2650-2663

  Dimitrova, Irina K ^a   Richer, Jennifer K ^b   Rudolph, Michael C ^a   Spoelstra, Nicole S ^b   Reno, Elaine M ^a   Medina, Theresa M ^b   Bradford, Andrew P ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

desmoglein; Fibroid; fibulins; gene expression; matrix metalloproteinases; microarray; MST4; myometrium; PKC 1; uterine leiomyoma

Indexed keywords

FIBULIN; MATRILYSIN; MESSENGER RNA; PROTEIN KINASE C BETA; PROTEIN SERINE THREONINE KINASE; STROMELYSIN 3;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; MYOMETRIUM; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TISSUE SECTION; UNINDEXED SEQUENCE; UTERUS MYOMA; WESTERN BLOTTING;

BASE SEQUENCE; DNA PRIMERS; DNA, COMPLEMENTARY; DNA, NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LEIOMYOMA; MATRIX METALLOPROTEINASE 11; MYOMETRIUM; PROTEIN-SERINE-THREONINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; UTERINE NEOPLASMS;

EID: 67349128323     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.03.071     Document Type: Article

References (71)

1. Cesen-Cummings K., Copland J.A., Barrett J.C., Walker C.L., and Davis B.J. Pregnancy, parturition, and prostaglandins: defining uterine leiomyomas. Environ Health Perspect 108 Suppl 5 (2000) 817-820
2. Ligon A.H., and Morton C.C. Leiomyomata: heritability and cytogenetic studies. Hum Reprod Update 7 (2001) 8-14
3. Buttram Jr. V.C. Uterine leiomyomata-aetiology, symptomatology and management. Prog Clin Biol Res 225 (1986) 275-296
4. Norris H.J., and Parmley T. Mesenchymal tumors of the uterus. V. Intravenous leiomyomatosis. A clinical and pathologic study of 14 cases. Cancer 36 (1975) 2164-2178
5. Cramer S.F., and Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol 94 (1990) 435-438
6. Velebil P., Wingo P.A., Xia Z., Wilcox L.S., and Peterson H.B. Rate of hospitalization for gynecologic disorders among reproductive-age women in the United States. Obstet Gynecol 86 (1995) 764-769
7. Stewart E.A. Uterine fibroids. Lancet 357 (2001) 293-298
8. Wilcox L.S., Koonin L.M., Pokras R., Strauss L.T., Xia Z., and Peterson H.B. Hysterectomy in the United States, 1988-1990. Obstet Gynecol 83 (1994) 549-555
9. Lepine L.A., Hillis S.D., Marchbanks P.A., Koonin L.M., Morrow B., Kieke B.A., et al. Hysterectomy surveillance-United States, 1980-1993. MMWR CDC Surveill Summ 46 (1997) 1-15
10. Hever A., Roth R.B., Hevezi P.A., Lee J., Willhite D., White E.C., et al. Molecular characterization of human adenomyosis. Mol Hum Reprod 12 (2006) 737-748
11. Vanharanta S., Wortham N.C., Laiho P., Sjoberg J., Aittomaki K., Arola J., et al. 7q deletion mapping and expression profiling in uterine fibroids. Oncogene 24 (2005) 6545-6554
12. Weston G., Trajstman A.C., Gargett C.E., Manuelpillai U., Vollenhoven B.J., and Rogers P.A. Fibroids display an anti-angiogenic gene expression profile when compared with adjacent myometrium. Mol Hum Reprod 9 (2003) 541-549
13. Tsibris J.C., Segars J., Coppola D., Mane S., Wilbanks G.D., O'Brien W.F., et al. Insights from gene arrays on the development and growth regulation of uterine leiomyomata. Fertil Steril 78 (2002) 114-121
14. Luo X., Ding L., Xu J., Williams R.S., and Chegini N. Leiomyoma and myometrial gene expression profiles and their responses to gonadotropin-releasing hormone analog therapy. Endocrinology 146 (2005) 1074-1096
15. Chegini N., Verala J., Luo X., Xu J., and Williams R.S. Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy. J Soc Gynecol Investig 10 (2003) 161-171
16. Skubitz K.M., and Skubitz A.P. Differential gene expression in leiomyosarcoma. Cancer 98 (2003) 1029-1038
17. Catherino W.H., Prupas C., Tsibris J.C., Leppert P.C., Payson M., Nieman L.K., et al. Strategy for elucidating differentially expressed genes in leiomyomata identified by microarray technology. Fertil Steril 80 (2003) 282-290
18. Wang H., Mahadevappa M., Yamamoto K., Wen Y., Chen B., Warrington J.A., et al. Distinctive proliferative phase differences in gene expression in human myometrium and leiomyomata. Fertil Steril 80 (2003) 266-276
19. Kanamori T., Takakura K., Mandai M., Kariya M., Fukuhara K., Kusakari T., et al. PEP-19 overexpression in human uterine leiomyoma. Mol Hum Reprod 9 (2003) 709-717
20. Ahn W.S., Kim K.W., Bae S.M., Yoon J.H., Lee J.M., Namkoong S.E., et al. Targeted cellular process profiling approach for uterine leiomyoma using cDNA microarray, proteomics and gene ontology analysis. Int J Exp Pathol 84 (2003) 267-279
21. Quade B.J., Wang T.Y., Sornberger K., Dal Cin P., Mutter G.L., and Morton C.C. Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling. Genes Chromosomes Cancer 40 (2004) 97-108
22. Hoffman P.J., Milliken D.B., Gregg L.C., Davis R.R., and Gregg J.P. Molecular characterization of uterine fibroids and its implication for underlying mechanisms of pathogenesis. Fertil Steril 82 (2004) 639-649
23. Lee E.J., Kong G., Lee S.H., Rho S.B., Park C.S., Kim B.G., et al. Profiling of differentially expressed genes in human uterine leiomyomas. Int J Gynecol Cancer 15 (2005) 146-154
24. Arslan A.A., Gold L.I., Mittal K., Suen T.C., Belitskaya-Levy I., Tang M.S., et al. Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review. Hum Reprod 20 (2005) 852-863
25. Roth T.M., Klett C., and Cowan B.D. Expression profile of several genes in human myometrium and uterine leiomyoma. Fertil Steril 87 (2007) 635-641
26. Catherino W.H., and Segars J.H. Microarray analysis in fibroids: which gene list is the correct list?. Fertil Steril 80 (2003) 293-294
27. Reno E.M., Haughian J.M., Dimitrova I.K., Jackson T.A., Shroyer K.R., and Bradford A.P. Analysis of protein kinase C delta (PKCdelta) expression in endometrial tumors. Hum Pathol 39 (2008) 21-29
28. Haughian J.M., Jackson T.A., Koterwas D.M., and Bradford A.P. Endometrial cancer cell survival and apoptosis is regulated by protein kinase C alpha and delta. Endocr Relat Cancer 13 (2006) 1251-1267
29. Bolstad B.M., Irizarry R.A., Astrand M., and Speed T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19 (2003) 185-193
30. Rudolph M.C., Neville M.C., and Anderson S.M. Lipid synthesis in lactation: diet and the Fatty Acid switch. J Mammary Gland Biol Neoplasia 12 (2007) 269-281
31. Hodge J.C., and Morton C.C. Genetic heterogeneity among uterine leiomyomata: insights into malignant progression. Hum Mol Genet 16 Spec No 1 (2007) R7-R13
32. Shimada K., Ohashi I., Kasahara I., Watanabe H., Ohta S., Miyasaka N., et al. Differentiation between completely hyalinized uterine leiomyomas and ordinary leiomyomas: three-phase dynamic magnetic resonance imaging (MRI) vs. diffusion-weighted MRI with very small b-factors. J Magn Reson Imaging 20 (2004) 97-104
33. Shimada K., Ohashi I., Kasahara I., Miyasaka N., and Shibuya H. Triple-phase dynamic MRI of intratumoral vessel density and hyalinization grade in uterine leiomyomas. AJR Am J Roentgenol 182 (2004) 1043-1050
34. Bell S.W., Kempson R.L., and Hendrickson M.R. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol 18 (1994) 535-558
35. Kempson R.L., and Bari W. Uterine sarcomas. Classification, diagnosis, and prognosis. Hum Pathol 1 (1970) 331-349
36. Kempson R.L., and Hendrickson M.R. Smooth muscle, endometrial stromal, and mixed Mullerian tumors of the uterus. Mod Pathol 13 (2000) 328-342
37. Hart W.R. Problematic uterine smooth muscle neoplasms. Am J Surg Pathol 21 (1997) 252-255
38. Perou C.M., Sorlie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Rees C.A., et al. Molecular portraits of human breast tumours. Nature 406 (2000) 747-752
39. Zaitseva M., Vollenhoven B.J., and Rogers P.A. In vitro culture significantly alters gene expression profiles and reduces differences between myometrial and fibroid smooth muscle cells. Mol Hum Reprod 12 (2006) 187-207
40. Gallagher W.M., Currid C.A., and Whelan L.C. Fibulins and cancer: friend or foe?. Trends Mol Med 11 (2005) 336-340
41. Luo X., Ding L., Xu J., and Chegini N. Gene expression profiling of leiomyoma and myometrial smooth muscle cells in response to transforming growth factor-beta. Endocrinology 146 (2005) 1097-1118
42. Luo X., Ding L., and Chegini N. CCNs, fibulin-1C and S100A4 expression in leiomyoma and myometrium: inverse association with TGF-β and regulation by TGF-β in leiomyoma and myometrial smooth muscle cells. Mol Hum Reprod 12 (2006) 245-256
43. Hayashido Y., Lucas A., Rougeot C., Godyna S., Argraves W.S., and Rochefort H. Estradiol and fibulin-1 inhibit motility of human ovarian- and breast-cancer cells induced by fibronectin. Int J Cancer 75 (1998) 654-658
44. Twal W.O., Czirok A., Hegedus B., Knaak C., Chintalapudi M.R., Okagawa H., et al. Fibulin-1 suppression of fibronectin-regulated cell adhesion and motility. J Cell Sci 114 (2001) 4587-4598
45. Qing J., Maher V.M., Tran H., Argraves W.S., Dunstan R.W., and McCormick J.J. Suppression of anchorage-independent growth and matrigel invasion and delayed tumor formation by elevated expression of fibulin-1D in human fibrosarcoma-derived cell lines. Oncogene 15 (1997) 2159-2168
46. Schiemann W.P., Blobe G.C., Kalume D.E., Pandey A., and Lodish H.F. Context-specific effects of fibulin-5 (DANCE/EVEC) on cell proliferation, motility, and invasion. Fibulin-5 is induced by transforming growth factor-beta and affects protein kinase cascades. J Biol Chem 277 (2002) 27367-27377
47. Albig A.R., and Schiemann W.P. Fibulin-5 antagonizes vascular endothelial growth factor (VEGF) signaling and angiogenic sprouting by endothelial cells. DNA Cell Biol 23 (2004) 367-379
48. Albig A.R., Neil J.R., and Schiemann W.P. Fibulins 3 and 5 antagonize tumor angiogenesis in vivo. Cancer Res 66 (2006) 2621-2629
49. Lecka-Czernik B., Lumpkin Jr. C.K., and Goldstein S. An overexpressed gene transcript in senescent and quiescent human fibroblasts encoding a novel protein in the epidermal growth factor-like repeat family stimulates DNA synthesis. Mol Cell Biol 15 (1995) 120-128
50. Spencer J.A., Hacker S.L., Davis E.C., Mecham R.P., Knutsen R.H., Li D.Y., et al. Altered vascular remodeling in fibulin-5-deficient mice reveals a role of fibulin-5 in smooth muscle cell proliferation and migration. Proc Natl Acad Sci USA 102 (2005) 2946-2951
51. Nava P., Laukoetter M.G., Hopkins A.M., Laur O., Gerner-Smidt K., Green K.J., et al. Desmoglein-2: a novel regulator of apoptosis in the intestinal epithelium. Mol Biol Cell 18 (2007) 4565-4578
52. Brennan D., Hu Y., Joubeh S., Choi Y.W., Whitaker-Menezes D., O'Brien T., et al. Suprabasal Dsg2 expression in transgenic mouse skin confers a hyperproliferative and apoptosis-resistant phenotype to keratinocytes. J Cell Sci 120 (2007) 758-771
53. Yashiro M., Nishioka N., and Hirakawa K. Decreased expression of the adhesion molecule desmoglein-2 is associated with diffuse-type gastric carcinoma. Eur J Cancer 42 (2006) 2397-2403
54. Sung V., Luo W., Qian D., Lee I., Jallal B., and Gishizky M. The Ste20 kinase MST4 plays a role in prostate cancer progression. Cancer Res 63 (2003) 3356-3363
55. Eude I., Dallot E., Vacher-Lavenu M.C., Chapron C., Ferre F., and Breuiller-Fouche M. Potentiation response of cultured human uterine leiomyoma cells to various growth factors by endothelin-1: role of protein kinase C. Eur J Endocrinol 144 (2001) 543-548
56. Yamamoto H., Sato H., Shibata S., Murata M., Fukuda J., and Tanaka T. Involvement of annexin V in the antiproliferative effect of GnRH agonist on cultured human uterine leiomyoma cells. Mol Hum Reprod 7 (2001) 169-173
57. Palmer S.S., Haynes-Johnson D., Diehl T., and Nowak R.A. Increased expression of stromelysin 3 mRNA in leiomyomas (uterine fibroids) compared with myometrium. J Soc Gynecol Investig 5 (1998) 203-209
58. Miyata Y., Iwata T., Ohba K., Kanda S., Nishikido M., and Kanetake H. Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis. Clin Cancer Res 12 (2006) 6998-7003
59. Noriyuki M., Sumi T., Zhi X., Misugi F., Nobeyama H., Yoshida H., et al. Vascular endothelial growth factor, matrix metalloproteinases, and cyclooxygenase-2 influence prognosis of uterine cervical cancer in young women. Int J Oncol 31 (2007) 531-536
60. Maurel J., Nadal C., Garcia-Albeniz X., Gallego R., Carcereny E., Almendro V., et al. Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients. Int J Cancer 121 (2007) 1066-1071
61. Wang F.Q., So J., Reierstad S., and Fishman D.A. Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase. Int J Cancer 114 (2005) 19-31
62. Misugi F., Sumi T., Okamoto E., Nobeyama H., Hattori K., Yoshida H., et al. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis. Int J Mol Med 16 (2005) 541-546
63. Lobel M.K., Somasundaram P., and Morton C.C. The genetic heterogeneity of uterine leiomyomata. Obstet Gynecol Clin North Am 33 (2006) 13-39
64. Stewart E.A., and Morton C.C. The genetics of uterine leiomyomata: what clinicians need to know. Obstet Gynecol 107 (2006) 917-921
65. Zaitseva M., Vollenhoven B.J., and Rogers P.A. Retinoic acid pathway genes show significantly altered expression in uterine fibroids when compared with normal myometrium. Mol Hum Reprod 13 (2007) 577-585
66. Wei T., Geiser A.G., Qian H.R., Su C., Helvering L.M., Kulkarini N.H., et al. DNA microarray data integration by ortholog gene analysis reveals potential molecular mechanisms of estrogen-dependent growth of human uterine fibroids. BMC Womens Health 7 (2007) 5
67. Catherino W.H., and Malik M. Uterine leiomyomas express a molecular pattern that lowers retinoic acid exposure. Fertil Steril 87 (2007) 1388-1398
68. Lattuada D., Vigano P., Mangioni S., Sassone J., Di Francesco S., Vignali M., et al. Accumulation of retinoid X receptor-alpha in uterine leiomyomas is associated with a delayed ligand-dependent proteasome-mediated degradation and an alteration of its transcriptional activity. Mol Endocrinol 21 (2007) 602-612
69. Politi K., Szabolcs M., Fisher P., Kljuic A., Ludwig T., and Efstratiadis A. A mouse model of uterine leiomyosarcoma. Am J Pathol 164 (2004) 325-336
70. Matsumura N., Mandai M., Miyanishi M., Fukuhara K., Baba T., Higuchi T., et al. Oncogenic property of acrogranin in human uterine leiomyosarcoma: direct evidence of genetic contribution in in vivo tumorigenesis. Clin Cancer Res 12 (2006) 1402-1411
71. Schwartz P.E., and Kelly M.G. Malignant transformation of myomas: myth or reality?. Obstet Gynecol Clin North Am 33 (2006) 183-198 xii